Yovanni Casablanca

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer”.

Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer

Cell Reports(2020)10.1016/j.celrep.2020.03.066

N/A

2.9DataRank · unranked

143 citations

Li Zhao, Christine Rojas, Nicholas W. Bateman, Hui Yao, Olivia D. Lara +41 more

Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.01.025

N/A

2.5DataRank · unranked

85 citations

Virginia L. Filiaci, Adrianne Mallen, Kristina W. Thiel, Eric J. Devor, Katherine Moxley +17 more

CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study

Cancer(2022)10.1002/cncr.34582

N/A

1.2DataRank · unranked

46 citations

Ashley Weir, Nicola S. Meagher, Kyo Farrington, Gregg Nelson, Prafull Ghatage +95 more

Racial disparities in survival among women with endometrial cancer in an equal access system

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.07.022

N/A

0DataRank · unranked

45 citations

Kathleen M. Darcy, Chunqiao Tian, Yovanni Casablanca, Jill Schinkel, Lindsey Enewold +4 more

MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma

Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin(2021)10.1007/s00428-021-03232-0

N/A

0DataRank · unranked

23 citations

Joshua Millstein, Gordana Popović, Nicola S. Meagher, Adelyn Bolithon, Aline Talhouk +95 more

Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1893

N/A

0DataRank · unranked

21 citations

Franklin Ning, Anna Duemler, Timothy G. Myers, Kathryn Trewhitt, Irene Ekwede +24 more

The clinical and prognostic significance of pre-chemotherapy serum CA-125 in high-risk early stage ovarian cancer: An NRG/GOG ancillary study

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.09.028

N/A

0DataRank · unranked

14 citations

Chunqiao Tian, Joshua P. Kesterson, Michael Richardson, Ken Lin, Krishnansu S. Tewari +14 more

Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypes

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.01.009

N/A

0DataRank · unranked

9 citations

Chunqiao Tian, Yovanni Casablanca, Nicholas W. Bateman, Suzanne Jokajtys, Calen Kucera +20 more

Sexual harassment and gender discrimination in gynecologic oncology

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.08.014

N/A

0DataRank · unranked

20 citations

Christopher M. Tarney, Kenneth Seier, Yovanni Casablanca, Carol L. Brown, Marina Stasenko

Beyond Sedlis—A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.06.017

N/A

0DataRank · unranked

62 citations

Anna Beavis, Christopher Purdy, Anne F. Rositch, Akila N. Viswanathan, Aaron H. Wolfson +16 more